119 related articles for article (PubMed ID: 38383496)
1. SMARCA4 Loss and Mutated β-Catenin Induce Proliferative Lesions in the Murine Embryonic Cerebellum.
Göbel C; Schoof M; Holdhof D; Spohn M; Schüller U
J Neurosci; 2024 Apr; 44(15):. PubMed ID: 38383496
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of β-catenin in neural progenitors results in disrupted proliferation and migration of neurons within the central nervous system.
Pöschl J; Grammel D; Dorostkar MM; Kretzschmar HA; Schüller U
Dev Biol; 2013 Feb; 374(2):319-32. PubMed ID: 23237957
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Molecular Profiling of Sinonasal Teratocarcinosarcoma Highlights Recurrent SMARCA4 Inactivation and CTNNB1 Mutations.
Rooper LM; Agaimy A; Gagan J; Simpson RHW; Thompson LDR; Trzcinska AM; Ud Din N; Bishop JA
Am J Surg Pathol; 2023 Feb; 47(2):224-233. PubMed ID: 36206446
[TBL] [Abstract][Full Text] [Related]
4. MYC overexpression and SMARCA4 loss cooperate to drive medulloblastoma formation in mice.
Göbel C; Godbole S; Schoof M; Holdhof D; Kresbach C; Loose C; Neumann J; Schüller U
Acta Neuropathol Commun; 2023 Nov; 11(1):174. PubMed ID: 37919824
[TBL] [Abstract][Full Text] [Related]
5. Dominant-stable beta-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model.
Boerboom D; White LD; Dalle S; Courty J; Richards JS
Cancer Res; 2006 Feb; 66(4):1964-73. PubMed ID: 16488995
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors.
Koch A; Waha A; Tonn JC; Sörensen N; Berthold F; Wolter M; Reifenberger J; Hartmann W; Friedl W; Reifenberger G; Wiestler OD; Pietsch T
Int J Cancer; 2001 Aug; 93(3):445-9. PubMed ID: 11433413
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
Koch A; Hrychyk A; Hartmann W; Waha A; Mikeska T; Waha A; Schüller U; Sörensen N; Berthold F; Goodyer CG; Wiestler OD; Birchmeier W; Behrens J; Pietsch T
Int J Cancer; 2007 Jul; 121(2):284-91. PubMed ID: 17373666
[TBL] [Abstract][Full Text] [Related]
8. Imbalanced Activation of Wnt-/β-Catenin-Signaling in Liver Endothelium Alters Normal Sinusoidal Differentiation.
Koch PS; Sandorski K; Heil J; Schmid CD; Kürschner SW; Hoffmann J; Winkler M; Staniczek T; de la Torre C; Sticht C; Schledzewski K; Taketo MM; Trogisch FA; Heineke J; Géraud C; Goerdt S; Olsavszky V
Front Physiol; 2021; 12():722394. PubMed ID: 34658910
[TBL] [Abstract][Full Text] [Related]
9. Beta-catenin (CTNNB1) promotes preovulatory follicular development but represses LH-mediated ovulation and luteinization.
Fan HY; O'Connor A; Shitanaka M; Shimada M; Liu Z; Richards JS
Mol Endocrinol; 2010 Aug; 24(8):1529-42. PubMed ID: 20610534
[TBL] [Abstract][Full Text] [Related]
10. CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants.
Silva Rd; Marie SK; Uno M; Matushita H; Wakamatsu A; Rosemberg S; Oba-Shinjo SM
Clinics (Sao Paulo); 2013; 68(2):167-72. PubMed ID: 23525311
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Wnt/β-catenin signaling induces Wnt and BMP antagonists in dental epithelium.
Chen X; Liu J; Li N; Wang Y; Zhou N; Zhu L; Shi Y; Wu Y; Xiao J; Liu C
Organogenesis; 2019; 15(2):55-67. PubMed ID: 31240991
[TBL] [Abstract][Full Text] [Related]
12. Molecular stratification of medulloblastoma: comparison of histological and genetic methods to detect Wnt activated tumours.
Goschzik T; Zur Mühlen A; Kristiansen G; Haberler C; Stefanits H; Friedrich C; von Hoff K; Rutkowski S; Pfister SM; Pietsch T
Neuropathol Appl Neurobiol; 2015 Feb; 41(2):135-44. PubMed ID: 24894640
[TBL] [Abstract][Full Text] [Related]
13. Genomic and transcriptomic analyses match medulloblastoma mouse models to their human counterparts.
Pöschl J; Stark S; Neumann P; Gröbner S; Kawauchi D; Jones DT; Northcott PA; Lichter P; Pfister SM; Kool M; Schüller U
Acta Neuropathol; 2014 Jul; 128(1):123-36. PubMed ID: 24871706
[TBL] [Abstract][Full Text] [Related]
14. Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis.
Lee SH; Luong R; Johnson DT; Cunha GR; Rivina L; Gonzalgo ML; Sun Z
Oncogene; 2016 Feb; 35(6):702-14. PubMed ID: 25893287
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous Brg1 Knockout and MYCN Overexpression in Cerebellar Granule Neuron Precursors Is Insufficient to Drive Tumor Formation but Temporarily Enhances their Proliferation and Delays their Migration.
Holdhof D; On JH; Schoof M; Göbel C; Schüller U
Cerebellum; 2021 Jun; 20(3):410-419. PubMed ID: 33387268
[TBL] [Abstract][Full Text] [Related]
16. PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis.
Jefferies MT; Cox AC; Shorning BY; Meniel V; Griffiths D; Kynaston HG; Smalley MJ; Clarke AR
J Pathol; 2017 Dec; 243(4):442-456. PubMed ID: 29134654
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-catenin signaling contributes to articular cartilage homeostasis through lubricin induction in the superficial zone.
Xuan F; Yano F; Mori D; Chijimatsu R; Maenohara Y; Nakamoto H; Mori Y; Makii Y; Oichi T; Taketo MM; Hojo H; Ohba S; Chung UI; Tanaka S; Saito T
Arthritis Res Ther; 2019 Nov; 21(1):247. PubMed ID: 31771658
[TBL] [Abstract][Full Text] [Related]
18. A CTNNB1-altered medulloblastoma shows the immunophenotypic, DNA methylation and transcriptomic profiles of SHH-activated, and not WNT-activated, medulloblastoma.
Chiang J; Moreira DC; Pytel NJ; Liu YC; Blackburn PR; Shi Z; Cardenas M; Wheeler DA; Furtado LV
Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12815. PubMed ID: 35320876
[TBL] [Abstract][Full Text] [Related]
19. An oncogenic CTNNB1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinoma.
Kim Y; Ahn B; Yoon S; Lee G; Kim D; Chun SM; Kim HR; Jang SJ; Hwang HS
PLoS One; 2023; 18(6):e0287256. PubMed ID: 37347751
[TBL] [Abstract][Full Text] [Related]
20. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
